Roche to reintroduce eye implant med Susvimo 2 years after recall

Roche's launch of eye implant Susvimo was stopped short in 2022 after manufacturing concerns led to a market withdrawal. Now, with the FDA’s blessing to reintroduce the therapy, the rollout can resume.